Quantinno Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-54,730
Closed -$5.56M 3330
2025
Q4
$5.56M Buy
54,730
+23,661
+76% +$1.9M 0.01% 1003
2025
Q3
$1.7M Buy
31,069
+7,250
+30% +$362K ﹤0.01% 1278
2025
Q2
$1.27M Buy
23,819
+14,715
+162% +$748K 0.01% 1240
2025
Q1
$394K Sell
9,104
-887
-9% -$44.9K ﹤0.01% 1484
2024
Q4
$561K Buy
9,991
+6,720
+205% +$418K 0.01% 1201
2024
Q3
$223K Buy
+3,271
New +$185K ﹤0.01% 1356

Other funds holding EXAS

Quantinno Capital Management's EXAS Position: Q1 2026 in Review

Quantinno Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 54,730 shares — an estimated $5.56M sold.

Quantinno Capital Management first reported a position in EXAS in Q3 2024 and held it in 6 quarters. The position peaked at $5.56M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Quantinno Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Quantinno Capital Management sold 54,730 Exact Sciences shares in Q1 2026, an estimated $5.56M.
  • Quantinno Capital Management first reported a position in Exact Sciences in Q3 2024 and held it in 6 quarters.
  • Quantinno Capital Management's Exact Sciences position peaked at $5.56M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.